This inventor holds 2 USPTO granted patents. Top assignees: Glaxosmithkline LLC, Smithkline Beecham Corporation. Active years: 2008-2010.
Company Filing History:
Years Active: 2008-2010
Title: Matthew Jude Sharp: Innovator in Arylethanoldiamines
Introduction
Matthew Jude Sharp is a notable inventor based in Durham, NC (US). He has made significant contributions to the field of chemistry, particularly in the preparation of arylethanoldiamines. With a total of 2 patents, his work has implications in the development of compounds that act as agonists at atypical beta-adrenoceptors.
Latest Patents
Sharp's latest patents focus on an improved process for preparing arylethanoldiamines. These compounds are recognized for their utility as agonists at atypical beta-adrenoceptors, also known as beta-3-adrenoceptors. His innovative approach enhances the efficiency of synthesizing these important chemical entities.
Career Highlights
Throughout his career, Matthew Jude Sharp has worked with prominent companies in the pharmaceutical industry, including SmithKline Beecham Corporation and GlaxoSmithKline LLC. His experience in these organizations has contributed to his expertise in the field and has allowed him to develop valuable patents.
Collaborations
Sharp has collaborated with several professionals in his field, including Ronnie Maxwell Lawrence and Jason William Beames Cooke. These partnerships have likely enriched his research and development efforts.
Conclusion
Matthew Jude Sharp's contributions to the field of chemistry, particularly through his patents on arylethanoldiamines, highlight his role as an innovator. His work continues to influence the development of important pharmaceutical compounds.